Cost-effectiveness Analysis of Cervical Cancer Screening with Papsure in Taiwan

碩士 === 國立陽明大學 === 醫務管理研究所 === 100 === Background: Since 1998, U.S. Food and Drug Administration(FDA) has approved the Pap smear test plus speculoscopy (Papsure) testing for women over 30 years old of age about cervical cancer screening.The incidence and mortality rates are both high in Taiwan, but t...

Full description

Bibliographic Details
Main Authors: Yi-Chun Shih, 施宜君
Other Authors: Hui-Chu Lang
Format: Others
Language:zh-TW
Published: 2012
Online Access:http://ndltd.ncl.edu.tw/handle/67342926121161047632